Page 1 of Clinical Trials for Novartis [SPONSOR-COLLABORATORS], 2523 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Kinetics of B Cell Response in Infants Menjugate Vaccination
Last Updated: March 12, 2007
Condition(s): Prevention of Meningococcal Infection
2
Completed
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants
Last Updated: April 16, 2008
Condition(s): Prevention of Meningococcal Disease
3
Completed
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
Last Updated: April 26, 2011
Condition(s): Meningococcal Meningitis
4
Completed
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008
Last Updated: April 21, 2008
Condition(s): Seasonal Influenza; Vaccine
5
Completed
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents
Last Updated: March 12, 2012
Condition(s): Influenza
6
Completed
Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules
Last Updated: October 24, 2011
Condition(s): Meningococcal Disease
7
Completed
Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.
Last Updated: September 13, 2006
Condition(s): Influenza Disease
8
Completed
Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Last Updated: December 2, 2009
Condition(s): Influenza
9
Recruiting
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Last Updated: April 30, 2012
Condition(s): Bacterial Meningitis
10
Completed
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
Last Updated: March 12, 2007
Condition(s): Influenza
11
Completed
Safety and Immunogenicity of Chiron Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
Last Updated: April 16, 2008
Condition(s): Meningococcal Meningitis
12
Completed
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
Last Updated: April 22, 2008
Condition(s): Encephalitis, Tick-Borne
13
Active, not recruiting
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
Last Updated: August 30, 2011
Condition(s): Influenza
14
Completed
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
Last Updated: July 29, 2011
Condition(s): Meningitis, Meningococcal
15
Completed
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
Last Updated: September 13, 2006
Condition(s): Influenza
16
Completed
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
Last Updated: January 31, 2008
Condition(s): Prevention of Meningococcal Disease
17
Completed
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
Last Updated: September 13, 2006
Condition(s): Influenza
18
Completed
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
Last Updated: September 13, 2006
Condition(s): Influenza
19
Completed
Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
Last Updated: July 20, 2011
Condition(s): Meningococcal Disease
20
Completed
A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY
Last Updated: August 9, 2011
Condition(s): Meningococcal Disease; Meningococcal Meningitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Novartis

Page 1 of Clinical Trials for Novartis [SPONSOR-COLLABORATORS], 2523 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About